Recent findings suggest that melanoma cells with oncogenic mutations in the ERK pathway adjust the available feedback mechanisms to establish an ERK activity optimum, promoting maximal cancer cell growth and proliferation. This evidence concerns the gene MAPK1 and melanoma.